Cargando…
Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled releas...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699023/ https://www.ncbi.nlm.nih.gov/pubmed/34944769 http://dx.doi.org/10.3390/biomedicines9121953 |
_version_ | 1784620418153316352 |
---|---|
author | Moyano Rodríguez, Edelweiss Gomez-Mendoza, Miguel Pérez-Ruiz, Raúl Peñín, Beatriz Sampedro, Diego Caamaño, Antonio de la Peña O’Shea, Víctor A. |
author_facet | Moyano Rodríguez, Edelweiss Gomez-Mendoza, Miguel Pérez-Ruiz, Raúl Peñín, Beatriz Sampedro, Diego Caamaño, Antonio de la Peña O’Shea, Víctor A. |
author_sort | Moyano Rodríguez, Edelweiss |
collection | PubMed |
description | Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled release of drug molecules in the harsh microenvironment. Here, modified reaction time, thermal treatment, and pH conditions were controlled in the synthesis of NaYF(4):Yb,Tm up-converted (UC) material to improve its photoluminescence properties. The best blue-emission performance was achieved for the UC3 sample prepared through 24 h-synthesis without thermal treatment at a pH of 5, which promotes the presence of the β-phase and smaller particle size. NaYF(4):Yb,Tm has resulted in a highly efficient blue emitter material for light-driven drug release under near-IR wavelength. Thus, NaYF(4):Yb,Tm up-converted material promotes the N-O bond cleavage of the oxime ester of Ciprofloxacin (prodrug) as a highly efficient photosensitized drug delivery process. HPLC chromatography and transient absorption spectroscopy measurements were performed to evaluate the drug release conversion rate. UC3 has resulted in a very stable and easily recovered material that can be used in several reaction cycles. This straightforward methodology can be extended to other drugs containing photoactive chromophores and is present as an alternative for drug release systems. |
format | Online Article Text |
id | pubmed-8699023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86990232021-12-24 Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy Moyano Rodríguez, Edelweiss Gomez-Mendoza, Miguel Pérez-Ruiz, Raúl Peñín, Beatriz Sampedro, Diego Caamaño, Antonio de la Peña O’Shea, Víctor A. Biomedicines Article Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled release of drug molecules in the harsh microenvironment. Here, modified reaction time, thermal treatment, and pH conditions were controlled in the synthesis of NaYF(4):Yb,Tm up-converted (UC) material to improve its photoluminescence properties. The best blue-emission performance was achieved for the UC3 sample prepared through 24 h-synthesis without thermal treatment at a pH of 5, which promotes the presence of the β-phase and smaller particle size. NaYF(4):Yb,Tm has resulted in a highly efficient blue emitter material for light-driven drug release under near-IR wavelength. Thus, NaYF(4):Yb,Tm up-converted material promotes the N-O bond cleavage of the oxime ester of Ciprofloxacin (prodrug) as a highly efficient photosensitized drug delivery process. HPLC chromatography and transient absorption spectroscopy measurements were performed to evaluate the drug release conversion rate. UC3 has resulted in a very stable and easily recovered material that can be used in several reaction cycles. This straightforward methodology can be extended to other drugs containing photoactive chromophores and is present as an alternative for drug release systems. MDPI 2021-12-20 /pmc/articles/PMC8699023/ /pubmed/34944769 http://dx.doi.org/10.3390/biomedicines9121953 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Moyano Rodríguez, Edelweiss Gomez-Mendoza, Miguel Pérez-Ruiz, Raúl Peñín, Beatriz Sampedro, Diego Caamaño, Antonio de la Peña O’Shea, Víctor A. Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy |
title | Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy |
title_full | Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy |
title_fullStr | Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy |
title_full_unstemmed | Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy |
title_short | Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy |
title_sort | controlled synthesis of up-conversion nayf(4):yb,tm nanoparticles for drug release under near ir-light therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699023/ https://www.ncbi.nlm.nih.gov/pubmed/34944769 http://dx.doi.org/10.3390/biomedicines9121953 |
work_keys_str_mv | AT moyanorodriguezedelweiss controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy AT gomezmendozamiguel controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy AT perezruizraul controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy AT peninbeatriz controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy AT sampedrodiego controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy AT caamanoantonio controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy AT delapenaosheavictora controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy |